Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of Panax ginseng in Neurodegenerative Diseases.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Infectious causes of multiple sclerosis.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Progressive multiple sclerosis: The treatment gap.
Fatigue in multiple sclerosis - A brief review.
Oligodendrocytes and the early multiple sclerosis lesion.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Cyclophosphamide for multiple sclerosis.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Product Insert, Amiloride HCl Tablets
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.

Pages